Recall: D-0723-2021

Class II - Potentially Harmful

Class IIClassification

2021-07-29Initiated

TerminatedStatus

PAI Holdings, LLC. dba PharmacFirm

Product

Ethosuximide Oral Solution USP 250 mg/5 mL, 16 fl oz (473 mL), Rx ONLY, Pharmaceutical Associates, Inc. Greenville, SC 29605, NDC 0121-0670-16

Reason

Lack of CGMP: This recall is being carried out due to potential for carry over of Senna Syrup.

Distribution

Distributed Nationwide in the USA

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.